Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions DOI Open Access
Tuan D. Pham, Muy‐Teck Teh,

Domniki Chatzopoulou

и другие.

Опубликована: Авг. 9, 2024

Artificial Intelligence (AI) is revolutionizing head and neck cancer (HNC) care by providing innovative tools that enhance diagnostic accuracy personalize treatment strategies. This review highlights the advancements in AI technologies, including deep learning natural language processing, their applications HNC. The integration of with imaging techniques, genomics, electronic health records explored, emphasizing its role early detection, biomarker discovery, planning. Despite noticeable progress, challenges such as data quality, algorithmic bias, need for interdisciplinary collaboration remain. Emerging innovations like explainable AI, AI-powered robotics, real-time monitoring systems are poised to further advance field. Addressing these fostering among experts, clinicians, researchers crucial developing equitable effective applications. future HNC holds significant promise, offering potential breakthroughs diagnostics, personalized therapies, improved patient outcomes.

Язык: Английский

Salivary Biomarkers Identification: Advances in Standard and Emerging Technologies DOI Creative Commons

Vlad Denis Constantin,

Ionuț Luchian, Ancuța Goriuc

и другие.

Oral, Год журнала: 2025, Номер 5(2), С. 26 - 26

Опубликована: Апрель 9, 2025

Introduction: Salivary biomarkers have been extensively studied in relation to oral disease, such as periodontal cancer, and dental caries, well systemic conditions including diabetes, cardiovascular diseases, neurological disorders. Literature Review: A systematic literature review was conducted, analyzing recent advancements salivary biomarker research. Databases PubMed, Scopus, Web of Science were searched for relevant studies published the last decade. The selection criteria included focusing on identification, validation, clinical application diagnosing diseases. Various detection techniques, enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry, biosensor technologies, reviewed assess their effectiveness analysis. Specific biomarkers, inflammatory cytokines, oxidative stress markers, microRNAs, identified reliable indicators disease progression. Current Trends Future Perspectives: Advances proteomics, genomics, metabolomics significantly enhanced ability analyze with high sensitivity specificity. Despite promising findings, challenges remain standardizing sample collection, processing, analysis ensure reproducibility applicability. Conclusions: research should focus developing point-of-care diagnostic tools integrating artificial intelligence improve predictive accuracy biomarkers.

Язык: Английский

Процитировано

0

Monitoring oral health remotely: ethical considerations when using AI among vulnerable populations DOI Creative Commons
Colman McGrath,

Cindy Chau,

Gustavo Fabián Molina

и другие.

Frontiers in Oral Health, Год журнала: 2025, Номер 6

Опубликована: Апрель 14, 2025

Technological innovations in dentistry are revolutionizing the monitoring and management of oral health. This perspective article critically examines rapid expansion remote technologies—including artificial intelligence (AI)-driven diagnostics, electronic health records (EHR), wearable devices, mobile applications, chatbots—and discusses their ethical, legal, social implications. The accelerated adoption these digital tools, particularly wake COVID-19 pandemic, has enhanced accessibility to care while simultaneously raising significant concerns regarding patient consent, data privacy, algorithmic biases. We review current applications ranging from AI-assisted detection dental pathologies blockchain-enabled transfer within EHR systems, highlighting potential for improved diagnostic accuracy risks associated with over-reliance on assessments. Furthermore, we underscore challenges posed by divide, where disparities literacy access may inadvertently exacerbate existing socio-economic inequalities. calls development rigorous implementation ethical frameworks regulatory guidelines that ensure reliability, transparency, accountability innovations. By integrating multidisciplinary insights, our discussion aims foster a balanced approach maximizes clinical benefits emerging technologies safeguarding autonomy promoting equitable healthcare delivery.

Язык: Английский

Процитировано

0

Salivary Biomarkers in the Diagnosis and Prognosis of Oral Disease DOI
Ana Cláudia Garcia Rosa

IntechOpen eBooks, Год журнала: 2025, Номер unknown

Опубликована: Апрель 17, 2025

Salivary biomarkers have emerged as a noninvasive diagnostic tool for detecting and monitoring various diseases, including oral squamous cell carcinoma (OSCC), periodontal disease (PD), Sjögren’s syndrome (SS), potentially malignant disorders (OPMDs). Advances in salivaomics (including genomics, transcriptomics, proteomics, metabolomics, microbiomics) enabled the identification of disease-specific that reflect pathophysiological changes. Key include cytokines, enzymes, nucleic acids, metabolic markers, microbiome alterations. In OSCC, IL-1α, IL-1β, IL-6, IL-8, TNF-α, VEGF, matrix metalloproteinases (MMP-1 MMP-9), microRNAs, epigenetic markers (MGMT, DAPK1, RASSF1A), (elevated lactic acid, LDH, pipecolinic acid), shifts (F. nucleatum, P.gingivalis) are linked to tumoral initiation progression. OPMDs, elevated MMP-9, oxidative stress (ROS, NO) potential indicators inflammation transformation. PD, MMP-8, RANKL, OPG correlate with severity alveolar bone loss. SS, diverse cytokine profiles immune dysfunction glandular inflammation. Despite technological advancements, challenges remain optimizing point-of-care applications, standardizing biomarker protocols, validating clinical applications. Future research should focus on integrating multiomics technologies AI-driven enhance accuracy, reliability, applicability salivary diagnosing systemic diseases.

Язык: Английский

Процитировано

0

Transforming Growth Factor-β1 and its Soluble Receptor Type 2 in Saliva of Young Adults: Sex-Related Differences and Predictive Modeling of Salivary Concentrations DOI
Marija Milić, Bojan Dželetović,

Biljana Anđelski Radičević

и другие.

Archives of Oral Biology, Год журнала: 2025, Номер 175, С. 106279 - 106279

Опубликована: Май 3, 2025

Язык: Английский

Процитировано

0

Unexploited opportunities in oral disease biosensors and digital health integration DOI
Hichem Moulahoum, Faezeh Ghorbanizamani

Clinica Chimica Acta, Год журнала: 2025, Номер 576, С. 120401 - 120401

Опубликована: Май 30, 2025

Язык: Английский

Процитировано

0

Oral cancer: Biomarker landscape DOI

Ritu Soni,

Shankargouda Patil,

Jigna Shah

и другие.

Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 457 - 484

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Artificial Intelligence in Dentistry: Advancements in Periodontology and Other Specialties, Diagnosis, Treatment Planning, and Ethical Considerations" DOI Creative Commons
Hadeel Mazin Akram

Dentistry Review, Год журнала: 2025, Номер unknown, С. 100157 - 100157

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0

Leveraging artificial intelligence for perioperative cancer risk assessment of oral potentially malignant disorders DOI Creative Commons
John Adeoye, Yu‐Xiong Su

International Journal of Surgery, Год журнала: 2023, Номер 110(3), С. 1677 - 1686

Опубликована: Дек. 4, 2023

Oral potentially malignant disorders (OPMDs) are mucosal conditions with an inherent disposition to develop oral squamous cell carcinoma. Surgical management is the most preferred strategy prevent transformation in OPMDs, and surgical approaches treatment include conventional scalpel excision, laser surgery, cryotherapy, photodynamic therapy. However, reality, since all patients OPMDs will not carcinoma their lifetime, there a need stratify according risk of streamline intervention for highest risks. Artificial intelligence (AI) has potential integrate disparate factors influencing robust, precise, personalized cancer stratification OPMD than current methods determine resection, or re-excision. Therefore, this article overviews existing AI models tools, presents clinical implementation pathway, discusses necessary refinements aid application AI-based platforms practice.

Язык: Английский

Процитировано

6

Integration of precision medicine into the dental care setting DOI Creative Commons
Larissa Steigmann, Željka Perić Kačarević, Jessica Khoury

и другие.

Frontiers in Dental Medicine, Год журнала: 2024, Номер 5

Опубликована: Авг. 21, 2024

This narrative review aims to discuss the incorporation of novel medical concepts and tools into dental practice, with goal improving early diagnosis exploring new personalized treatment options for oral pathologies, such as caries periodontitis. Preventative approaches concentrate on timely detection infections integration biomarker analysis recognize pathogenic changes at stage disease. Likewise, periodic monitoring after is relevant ensure balance in biofilms prevent relapse. Additionally, more attention has shifted towards contributing factors disease development, essential nutrients. Sufficient levels vitamin C, D zinc pre- post-operatively are employed boost immune function reduce risk postoperative infections. Omega-3 fatty acids, melatonin, antioxidants like E, which have anti-inflammatory properties, utilized help minimize excessive inflammation promote faster recovery. The data presented this manuscript emphasize crucial innovative healthcare practices. By adopting a holistic view patient, clinicians can tailor treatments each individual's predispositions, lifestyle, health conditions. also highlights potential salivary biomarkers point-of-care technologies enhancing diagnostic accuracy personalizing treatment. Bridging gap between systemic most effective approach patient quality life. These findings underscore importance continued interdisciplinary collaboration dentistry.

Язык: Английский

Процитировано

1

The Role of Salivary Biomarkers in the Diagnosis of Oral Cancer DOI

Reihaneh Khalilianfard,

Mobina Sadat Zarabadi,

Sahar Hassantash

и другие.

Interdisciplinary cancer research, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

1